Skip to content

ISRAEL ACQUISITIONS CORP: 10-Q filed 2024-11-15

What ISRAEL ACQUISITIONS CORP reported in its quarterly report filed 2024-11-15 (fiscal Q3 2024): 21 published measures, 61 facts as tagged in accession 0001410578-24-002006.

This filing

Form
10-Q (quarterly report)
Filed
2024-11-15
Fiscal period
fiscal Q3 2024
Accession
0001410578-24-002006 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ISRAEL ACQUISITIONS CORP filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2024-09-3081,564,971USD
At 2023-12-31154,518,748USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2024-09-306,510,226USD
At 2023-12-315,668,518USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2024-09-30-6,454,223USD
At 2024-06-30-6,069,952USD
At 2024-03-31-5,627,752USD
At 2023-12-31-4,851,776USD
At 2023-09-30-4,546,349USD
At 2023-06-30-4,371,368USD
At 2023-03-31-4,159,585USD
At 2022-12-31-52,000USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2024-09-3026,702USD
At 2023-12-31671,628USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2024-07-01 to 2024-09-30810,926USD92
2024-01-01 to 2024-09-302,125,673USD274
2024-04-01 to 2024-06-30738,891USD91
2024-01-01 to 2024-03-31575,856USD91
2023-07-01 to 2023-09-301,769,706USD92
2023-01-19 to 2023-09-304,356,123USD255
2023-01-01 to 2023-09-304,349,477USD273
2023-04-01 to 2023-06-301,435,806USD91
2023-01-01 to 2023-03-311,143,965USD90
2023-01-01 to 2023-01-18-6,646USD18

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2024-01-01 to 2024-09-302,483,194USD274
2023-01-01 to 2023-09-30-665,095USD273

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2024-01-01 to 2024-09-30-75,321,158USD274
2023-01-01 to 2023-09-30148,150,365USD273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2024-01-01 to 2024-09-3072,193,038USD274
2023-01-01 to 2023-09-30-146,683,147USD273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2024-09-30-6,454,778USD
At 2023-12-31-4,852,331USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2024-07-01 to 2024-09-30-234,272USD92
2024-01-01 to 2024-09-30-1,159,728USD274
2023-07-01 to 2023-09-30-185,706USD92
2023-01-01 to 2023-09-30-731,022USD273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2024-09-3081,564,971USD
At 2023-12-31154,518,748USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2024-09-306,510,226USD
At 2023-12-315,668,518USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2024-09-30230,903USD
At 2023-12-3191,139USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2024-01-01 to 2024-09-3075,921,158USD274

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2024-09-3026,702USD
At 2023-12-31671,628USD
At 2023-09-30810,428USD
At 2022-12-318,305USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2024-09-30183,073USD
At 2023-12-3155,000USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2024-01-01 to 2024-09-302,125,673USD274
2023-01-01 to 2023-09-304,349,477USD273

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2024-07-01 to 2024-09-30-384,271USD92
2024-01-01 to 2024-09-30-1,602,447USD274
2023-07-01 to 2023-09-30-174,981USD92

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2024-07-01 to 2024-09-301,045,198USD92
2024-01-01 to 2024-09-303,285,401USD274
2023-07-01 to 2023-09-301,955,412USD92
2023-01-01 to 2023-09-305,080,499USD273

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2023-01-01 to 2023-09-30141,250,000USD273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2024-01-01 to 2024-09-30139,764USD274
2023-01-01 to 2023-09-3034,678USD273

Inspect the source

Entity
ISRAEL ACQUISITIONS CORP / CIK 0001915328
Captured
2026-09-21T17:23:56.290Z
SEC response SHA-256
10f00b4c7dab62910a8608764466b79e6bebac06ddfc661ea2b84d48224cd64b

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001915328.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))